Amedisys (AMED) Insider Trading & Ownership $90.00 +0.55 (+0.61%) (As of 11/19/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Amedisys (NASDAQ:AMED) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage1.80%Number OfInsiders Buying(Last 3 Years)1Amount OfInsider Buying(Last 3 Years)$141,250.00Number OfInsiders Selling(Last 3 Years)3Amount OfInsider Selling(Last 3 Years)$1.02 M Get AMED Insider Trade Alerts Want to know when executives and insiders are buying or selling Amedisys stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address AMED Insider Buying and Selling by Quarter Ad The Bull ReportAmazon's $150B Data Center Bet—What It Means for Uranium InvestorsAmazon is placing a massive bet on nuclear energy to power its $150 billion data center expansion. With demand for electricity skyrocketing from data centers, AI, and emerging tech, Amazon recognizes nuclear power as the only viable solution to meet its needs sustainably and at scale. But here's the critical catch: nuclear power requires uranium, and the global supply is struggling to keep up. Read More to Learn How You Can Position Yourself for the Next Uranium Boom Amedisys Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/3/2023Michael Paul NorthInsiderSell5,908$86.43$510,628.44 6/23/2022Denise M BohnertInsiderSell557$115.00$64,055.00 3/29/2022David L KemmerlyInsiderSell2,500$177.31$443,275.00 11/30/2021Richard A LechleiterDirectorBuy1,000$141.25$141,250.00 (Data available from 1/1/2013 forward) AMED Insider Trading Activity - Frequently Asked Questions Who is on Amedisys's Insider Roster? The list of insiders at Amedisys includes David L Kemmerly, Denise M Bohnert, Michael Paul North, and Richard A Lechleiter. Learn more on insiders at AMED. What percentage of Amedisys stock is owned by insiders? 1.80% of Amedisys stock is owned by insiders. Learn more on AMED's insider holdings. Which Amedisys insiders have been selling company stock? The following insider sold AMED shares in the last 24 months: Michael Paul North ($510,628.44). How much insider selling is happening at Amedisys? Insiders have sold a total of 5,908 Amedisys shares in the last 24 months for a total of $510,628.44 sold. Amedisys Key ExecutivesMr. Richard M. Ashworth (Age 49)President, CEO & Director Compensation: $2.2MMr. Scott G. Ginn (Age 55)Executive VP, COO, CFO & Principal Financial Officer Compensation: $1.36MMs. Denise Bohnert (Age 46)Chief Compliance Officer Compensation: $743.68kMr. Nick Muscato (Age 38)Chief Strategy Officer Compensation: $837.08kMs. Allyson GuidrozChief Accounting Officer & Principal Accounting OfficerMr. Pete HartleyCTO & Senior VP of Business Operations SystemsMs. Jennifer Guckert GriffinSenior VP, Deputy General Counsel, Corporate Secretary & Interim Chief Legal OfficerKendra KimmonsVP of Marketing & Communications & Media RelationsMs. Caitlin FranklinActing Chief People OfficerMr. Francis MayerSenior Vice President of Development More Insider Trading Tools from MarketBeat Related Companies CHE Insider Trading RCM Insider Trading CRVL Insider Trading MD Insider Trading AMN Insider Trading CCRN Insider Trading LH Insider Trading DGX Insider Trading DVA Insider Trading OPCH Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:AMED) was last updated on 11/20/2024 by MarketBeat.com Staff From Our PartnersAmazon's $150B Data Center Bet—What It Means for Uranium InvestorsAmazon is placing a massive bet on nuclear energy to power its $150 billion data center expansion. With dem...The Bull Report | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredA huge crack is forming in the US economyFormer Trump Advisor Warning: “An Economic Rupture Is Coming” The legendary financier Brad Thomas served on...Wide Moat Research | SponsoredThe Stock Powering Musk’s AI Revolution—RevealedImagine being able to invest in Tesla, PayPal, or SpaceX before the world knew their potential. Today, you ...InvestorPlace | SponsoredElon Musk In Trump’s “Inner Circle”Elon Musk is one of Donald Trump’s closest allies. Since the election, he’s spent several days at Mar-a-Lag...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amedisys, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amedisys With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
